The Trump administration has selected five companies, including Johnson &amp; Johnson $JNJ, Merck $MRK , Moderna Inc $MRNA, AstraZeneca Plc $AZN and Pfizer Inc $PFE, as the most likely candidates to produce a vaccine for the novel coronavirus

$GSK is the 6th company